Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7620500 Optimization of crossover points for directed evolution

Patent 7620500 was granted and assigned to Maxygen, Inc. on November, 2009 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
‌
Maxygen, Inc.
0
Date Filed
March 10, 2003
0
Date of Patent
November 17, 2009
0
Patent Application Number
10386903
0
Patent Citations Received
‌
US Patent 12129495 Engineered DNA polymerase variants
0
‌
US Patent 12018295 Engineered DNA polymerase variants
0
‌
US Patent 12071642 Engineered amylase variants
0
‌
US Patent 12084697 Penicillin-G acylases
0
‌
US Patent 12110493 Engineered purine nucleoside phosphorylase variant enzymes
0
‌
US Patent 12110521 Engineered methionine gamma lyase variants
0
‌
US Patent 12110513 Engineered pantothenate kinase variant enzymes
0
‌
US Patent 12129494 T7 RNA polymerase variants
0
‌
US Patent 11746369 Ketoreductase polypeptides and polynucleotides
‌
US Patent 11760981 Engineered glycosyltransferases and steviol glycoside glucosylation methods
•••
Patent Inventor Names
Claes Gustafsson
0
Emily C. Mundorff
0
Jeremy S. Minshull
0
Sridhar Govindarajan
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
7620500
0
Patent Primary Examiner
‌
John S. Brusca
0

Find more entities like US Patent 7620500 Optimization of crossover points for directed evolution

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.